Login / Signup

What Place Is There for Long-Acting Antibiotics in the Management of Gram-Positive Infections? A Qualitative Cross-Sectional Study.

Aurélien DinhGuillaume BéraudJohan CourjonYann Le GoffNicolas Kader EttaharMatthieu GrégoireEric Senneville
Published in: Antibiotics (Basel, Switzerland) (2024)
Long half-life lipoglycopeptides contribute to changing the paradigm in the management of acute bacterial infections, as infectiologists now consider a range of indications and patient profiles for one single drug. Oritavancin strengthens the therapeutic arsenal in numerous infections from BJIs to urinary tract infections and could help to manage specific clinical situations, on top of providing potential benefits for the hospital's budget.
Keyphrases
  • urinary tract infection
  • healthcare
  • drug induced
  • adverse drug
  • emergency department
  • risk assessment
  • climate change
  • human health
  • electronic health record